首页|期刊导航|Cancer Innovation|Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor‐Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer

Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor‐Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer

Jian Xue Chuanbin Liu Jun Shao Li Wang Yating Han Jing Wang Jinda Wang

Cancer Innovation2025，Vol.4Issue(2)：P.60-67,8.

Cancer Innovation2025，Vol.4Issue(2)：P.60-67,8.DOI:10.1002/cai2.163

Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor‐Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer

Jian Xue ¹Chuanbin Liu ²Jun Shao ³Li Wang ⁴Yating Han ⁴Jing Wang ³Jinda Wang¹

作者信息

1. Senior Department of Cardiology,The Sixth Medical Center of Chinese PLA General Hospital,Beijing,China
2. Western Medical Branch of Chinese PLA General Hospital,Beijing,China Department of Emergency,The First Medical Center of Chinese PLA General Hospital,Beijing,China
3. Department of General Surgery,The First Medical Center of
4. Western Medical Branch of Chinese PLA General Hospital,Beijing,China
折叠

摘要

关键词

biomarkers/immune checkpoint inhibitors-related myocarditis/immunotherapy/neutrophil-to-lymphocyte ratio/non-small-cell lung cancer

分类

医药卫生

引用本文复制引用

Jian Xue,Chuanbin Liu,Jun Shao,Li Wang,Yating Han,Jing Wang,Jinda Wang..Predictive Value of Neutrophil-to-Lymphocyte Ratio for Immune Checkpoint Inhibitor‐Related Myocarditis Among Patients Treated for Non-Small-Cell Lung Cancer[J].Cancer Innovation,2025,4(2):P.60-67,8.

基金项目

supported by the Young Talent Project of Chinese PLA General Hospital(20230433). （20230433）

Cancer Innovation

ISSN：2770-9191

访问量0

下载量0

段落导航